The FDA has requested clinical trial data on saxagliptin (Onglyza and Kombiglyze XR) to investigate a possible increase in heart failure in patients taking the drug. ... The manufacturer is expected to submit the data to the FDA by early March 2014,
Afrezza, a rapid-acting, inhaled human insulin, was recently approved by the FDA to treat diabetes in adults. ... The most common adverse reactions in trials were hypoglycemia, cough, and throat pain or irritation, according to an FDA.
Certain models of the MiniMed insulin pump were recalled by Medtronic due to potential cybersecurity risks, the FDA warned on June 27. ... Because the manufacturer cannot update the MiniMed 508 and MiniMed Paradigm series insulin pump models, patients
New warnings will be placed on saxagliptin and alogliptin about the potential risk of heart failure, particularly in patients with heart or kidney disease, the FDA announced on April 5. ... The FDA recommends that clinicians consider discontinuing
The Abbott FreeStyle Insulinx blood glucose meters were recently recalled because at extremely high blood glucose levels of 1,024 mg/dL and above, the meters will display and store in memory an incorrect test result that is 1,024 mg/dL below the
Empagliflozin (Jardiance), a sodium glucose co-transporter 2 inhibitor, was recently approved to treat type 2 diabetes in addition to diet and exercise, the FDA announced last week. ... The FDA is requiring 4 postmarketing studies to investigate
Dapaglifozin (Farxiga), a new medication to treat type 2 diabetes, was recently approved by the FDA for use along with diet and exercise. ... The FDA also announced a recall of some TRUEbalance and TRUEtrack blood glucose meters by Nipro Diagnostics, Inc.
A new glucagon-like peptide-1 (GLP-1) receptor agonist, dulaglutide (Trulicity), was approved to treat type 2 diabetes, along with diet and exercise, the FDA recently announced. ... The FDA is requiring several postmarketing studies, including trials in
Lorcaserin hydrochloride (Belviq) was recently approved by the FDA for chronic weight management in adults. ... Lorcaserin hydrochloride (Belviq) was recently approved by the FDA for chronic weight management in adults with a body mass index (BMI) of 30
Two lots of metformin hydrochloride oral solution (Riomet), 500 mg/5 mL, were recalled due to fungal contamination, the FDA said. ... Sun Pharmaceutical Industries, Inc., has recalled two lots of metformin hydrochloride oral solution (Riomet), 500 mg/5 mL